The Epoch Times
The Epoch Times
Focus

Revance

Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 18, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 16, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 18, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

US FDA Declines to Approve Revance’s Frown-Line Treatment

Oct 16, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.